Hematopoiesis & Alzheimer's Disease

The formation of blood cells, hematopoiesis, has been exploited for the potential use as a therapy in Alzheimer’s disease. Decreased levels of lymphocytes and proteins involved in stem cell recruitment are found in early stages of Alzheimer’s disease. Here is the latest research on hematopoiesis and Alzheimer’s disease.

January 10, 2019

Blood chimerism in twins

Immunohematology
Letícia TavaresAlexandre Geraldo
January 16, 2018
Review
Open Access

Markers and Biomarkers of Endothelium: When Something Is Rotten in the State

Oxidative Medicine and Cellular Longevity
Nikolay V GoncharovPavel V Avdonin
April 10, 2019
Open Access

Neuroprotective effects of EpoL against oxidative stress induced by soluble oligomers of Aβ peptide

Redox Biology
C CastilloJorge Fuentealba
June 15, 2019
Open Access

Results of Allogenic Hematopoietic Stem Cell Transplantation in Fanconi Anemia Caused by Bone Marrow Failure: Single-Regimen, Single-Center Experience of 14 Years

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Gulen TuysuzAlphan Kupesiz
January 7, 2019
Open Access

Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer's disease

Journal of Neuroinflammation
Isabelle St-AmourFrédéric Calon
September 21, 2017
Case Report
Open Access

Immune-Mediated Autonomic Neuropathies following Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia

Case Reports in Hematology
Abhishek MangaonkarTaxiarchis Kourelis
June 10, 2017
Review
Open Access

Human IκBα Gain of Function: a Severe and Syndromic Immunodeficiency

Journal of Clinical Immunology
Bertrand BoissonJean-Laurent Casanova
January 19, 2019
Review
Open Access

The Promises and Challenges of Erythropoietin for Treatment of Alzheimer's Disease

Neuromolecular Medicine
Jiahong SunRachita K Sumbria
December 7, 2018
Open Access

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers

Frontiers in Immunology
Kelen Cristina Ribeiro MalmegrimMaria Carolina Oliveira
September 22, 2020
Case Report
Open Access

COVID - 19 post Hematopoietic Cell Transplant, a Report of 11 Cases from a Single Center

Mediterranean Journal of Hematology and Infectious Diseases
Alfadil HaroonRiad El Fakih
December 6, 2017
Clinical Trial
Open Access

Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Christen L EbensMargaret L MacMillan
December 28, 2017
Open Access

Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome

Journal of Alzheimer's Disease : JAD
Ruma Raha-ChowdhuryShahid H Zaman
June 3, 2017
Open Access

An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2

Drug Design, Development and Therapy
Tomer MeirsonHava Gil-Henn
March 7, 2018

MicroRNA-223 is involved in the pathogenesis of atopic dermatitis by affecting histamine-N-methyltransferase

Cellular and Molecular Biology
Hui-Zhen JiaWei Zhang
August 8, 2019

Effect of Stem Cell Source and Dose on Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Idiopathic Aplastic Anemia: Data from the Korean Aplastic Anemia Trials

Acta Haematologica
Hawk Kimon behalf of the Korean Society of Blood and Marrow Transplantation

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share a considerable proportion of characteristics including the same neuropathological substrate of abnormally phosphorylated TAR DNA binding protein (TDP-43). Here are the latest discoveries pertaining to ALS, FTD and TDP-43.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS - Stress Granules

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/hematopoiesis-alzheimers-disease/a821b3fb-abb7-4dfe-9f5e-76a90e512a94